about
Modes of paramyxovirus fusion: a Henipavirus perspectiveA general strategy to endow natural fusion-protein-derived peptides with potent antiviral activityFatal measles virus infection prevented by brain-penetrant fusion inhibitors.Inhibition of Nipah virus infection in vivo: targeting an early stage of paramyxovirus fusion activation during viral entryViral entry inhibitors targeted to the membrane site of action.Circulating clinical strains of human parainfluenza virus reveal viral entry requirements for in vivo infection.Prevention of measles virus infection by intranasal delivery of fusion inhibitor peptidesPremature activation of the paramyxovirus fusion protein before target cell attachment with corruption of the viral fusion machineryCapturing a fusion intermediate of influenza hemagglutinin with a cholesterol-conjugated peptide, a new antiviral strategy for influenza virus.Human parainfluenza virus infection of the airway epithelium: viral hemagglutinin-neuraminidase regulates fusion protein activation and modulates infectivity.A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.Cholesterol-conjugated peptide antivirals: a path to a rapid response to emerging viral diseases.Artificial peptides conjugated with cholesterol and pocket-specific small molecules potently inhibit infection by laboratory-adapted and primary HIV-1 isolates and enfuvirtide-resistant HIV-1 strains.The second receptor binding site of the globular head of the Newcastle disease virus hemagglutinin-neuraminidase activates the stalk of multiple paramyxovirus receptor binding proteins to trigger fusion.Spring-loaded model revisited: paramyxovirus fusion requires engagement of a receptor binding protein beyond initial triggering of the fusion protein.Infection of primary neurons mediated by nipah virus envelope proteins: role of host target cells in antiviral action.A quantitative and kinetic fusion protein-triggering assay can discern distinct steps in the nipah virus membrane fusion cascadeBiophysical Properties and Antiviral Activities of Measles Fusion Protein Derived Peptide Conjugated with 25-Hydroxycholesterol.New insights into measles virus propagation: from entry to shedding
P2860
Q24604089-85CB8EA6-9DC2-4747-AE80-509E096676B5Q28729918-DD96865C-F151-4303-B946-AC845499BE91Q30557599-976B1300-B951-4CE5-8042-7E291AD7CF60Q33741962-0FF77524-1B19-48F2-8FBA-E0C6E1C56DB2Q33990602-E3BB9BD7-D1BB-4301-9209-DB4695CF5AD7Q34594547-C4E3164E-B4DA-4D3F-8452-D85C204D3359Q34991022-34BD1551-118A-4457-AF6E-D151FADC7B8DQ35515383-D6D7820C-0FD0-4EA7-9BEC-CDD5D1AC873AQ35604856-F35D4C47-CC94-4944-AAED-D18450E17526Q37232820-8C035E64-7775-4F64-8BF4-5ED8E6F86C6EQ37720808-A6D94947-DFA7-4D74-B702-93A88CB3F0F0Q38261556-A2642CDA-B115-48DE-AF66-1C28FFA4297CQ39026832-982141A5-FCBA-4993-8987-AA870000D08CQ39375677-5D21819A-0209-4B43-AA6A-FEBB99DB0EDFQ39462591-8DEBBFB8-5617-4B98-95A3-E02614BEFE7DQ39528697-6193F84D-BFFB-4774-9EE3-9208AF6B5105Q39697289-BD84CE58-28AF-4DB3-A9BE-809500956216Q47582990-3919F4B0-3DAA-43DE-8E0B-13AC68D18EF5Q57702448-1B514976-AD9C-4DCD-BE23-0CEEFBB770D5
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Kinetic dependence of paramyxovirus entry inhibition.
@en
Kinetic dependence of paramyxovirus entry inhibition.
@nl
type
label
Kinetic dependence of paramyxovirus entry inhibition.
@en
Kinetic dependence of paramyxovirus entry inhibition.
@nl
prefLabel
Kinetic dependence of paramyxovirus entry inhibition.
@en
Kinetic dependence of paramyxovirus entry inhibition.
@nl
P2093
P2860
P356
P1433
P1476
Kinetic dependence of paramyxovirus entry inhibition
@en
P2093
Anne Moscona
Christine C Yokoyama
Gianmarco Orefice
Han-Sung Kim
Matteo Porotto
P2860
P304
P356
10.1128/JVI.00416-09
P407
P577
2009-04-15T00:00:00Z